A01567 Summary:

BILL NO    A01567 

SAME AS    SAME AS S00777

SPONSOR    Gottfried (MS)

COSPNSR    Paulin, Gunther, Rosenthal, Cahill, Galef, Englebright, Jaffee,
           Zebrowski, Hooper, Lupardo, Schimel, Titone, Brook-Krasny, Abinanti,
           Perry, Weprin, Kearns, McDonald

MLTSPNSR   Clark

Add S2424, Pub Health L

Establishes the clinical trial access and education fund to provide grants to
eligible applicants to provide certain services for patients with
life-threatening or disabling conditions or diseases.
Go to top

A01567 Actions:

BILL NO    A01567 

01/12/2015 referred to health
03/03/2015 reported referred to ways and means
06/03/2015 reported referred to rules
06/08/2015 reported 
06/08/2015 rules report cal.62
06/08/2015 ordered to third reading rules cal.62
06/08/2015 passed assembly
06/08/2015 delivered to senate
06/08/2015 REFERRED TO HEALTH
Go to top

A01567 Text:

                           S T A T E   O F   N E W   Y O R K
       ________________________________________________________________________

                                         1567

                              2015-2016 Regular Sessions

                                 I N  A S S E M B L Y

                                   January 12, 2015
                                      ___________

       Introduced  by  M.  of A. GOTTFRIED, PAULIN, GUNTHER, ROSENTHAL, CAHILL,
         GALEF,  ENGLEBRIGHT,  JAFFEE,  ZEBROWSKI,  HOOPER,  LUPARDO,  SCHIMEL,
         TITONE,  BROOK-KRASNY,  ABINANTI,  PERRY,  WEPRIN, KEARNS, McDONALD --
         Multi-Sponsored by -- M. of A. CLARK -- read once and referred to  the
         Committee on Health

       AN  ACT  to amend the public health law, in relation to establishing the
         clinical trial access and education fund

         THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
       BLY, DO ENACT AS FOLLOWS:

    1    Section  1.  The  public health law is amended by adding a new section
    2  2424 to read as follows:
    3    S 2424. CLINICAL TRIAL ACCESS AND EDUCATION FUND. 1. DEFINITIONS.  FOR
    4  THE PURPOSES OF THIS SECTION, THE FOLLOWING TERMS SHALL HAVE THE FOLLOW-
    5  ING MEANINGS:
    6    A. "ELIGIBLE APPLICANT" MEANS (I) A MEDICAL  SCHOOL  THAT  SPONSORS  A
    7  CLINICAL  TRIAL,  (II) A NOT-FOR-PROFIT ORGANIZATION WITH EXPERIENCE AND
    8  EXPERTISE WORKING  WITH  PATIENTS  WITH  LIFE-THREATENING  OR  DISABLING
    9  CONDITIONS OR DISEASES, (III) A HEALTH CARE PROVIDER ORGANIZATION, ASSO-
   10  CIATION   OR  SOCIETY,  (IV)  A  GENERAL  HOSPITAL  DEFINED  IN  ARTICLE
   11  TWENTY-EIGHT OF THIS CHAPTER, (V) A COUNTY OR CITY HEALTH DEPARTMENT, OR
   12  (VI) A MUNICIPALITY.
   13    B. "CLINICAL TRIAL" SHALL HAVE THE  SAME  MEANING  AS  IN  SUBDIVISION
   14  TWO-B OF SECTION FORTY-NINE HUNDRED OF THIS CHAPTER.
   15    2.  ESTABLISHMENT  OF  FUND.  THERE  IS  HEREBY ESTABLISHED WITHIN THE
   16  DEPARTMENT A CLINICAL TRIAL ACCESS AND EDUCATION FUND. SUBJECT TO APPRO-
   17  PRIATIONS, THE DEPARTMENT SHALL PROVIDE GRANTS TO ELIGIBLE APPLICANTS ON
   18  A COMPETITIVE REQUEST FOR PROPOSAL BASIS TO PROVIDE ONE OR MORE  OF  THE
   19  FOLLOWING SERVICES TO PATIENTS WITH LIFE-THREATENING OR DISABLING CONDI-
   20  TIONS  OR  DISEASES,  AS  SUCH  TERMS  ARE DEFINED IN SECTION FORTY-NINE
   21  HUNDRED OF THIS CHAPTER, TO FACILITATE ACCESS TO OR EDUCATION  ON  CLIN-
   22  ICAL TRIALS OF TREATMENTS FOR THE PATIENT'S CONDITION OR DISEASE:

        EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                             [ ] is old law to be omitted.
                                                                  LBD02409-01-5
       A. 1567                             2

    1    A. TRANSPORTATION SERVICES AND LODGING TO PROVIDE PATIENTS WITH ACCESS
    2  TO CLINICAL TRIALS OR OTHER RELATED TREATMENTS WHILE ENROLLED IN A CLIN-
    3  ICAL  TRIAL OR TO ACCESS TESTING AND OTHER SERVICES TO DETERMINE PATIENT
    4  ELIGIBILITY FOR A CLINICAL TRIAL;
    5    B.  PATIENT OUTREACH AND EDUCATION SERVICES TO EDUCATE PATIENTS, THEIR
    6  FAMILIES AND HEALTH CARE  PROVIDERS  ABOUT  THE  EXISTENCE  OF  AND  HOW
    7  PATIENTS  MAY ENROLL IN CLINICAL TRIALS, UNDER SECTION TWO HUNDRED SEVEN
    8  OF THIS CHAPTER; AND
    9    C. PATIENT NAVIGATION SERVICES TO HELP PATIENTS TO DETERMINE  IF  THEY
   10  ARE ELIGIBLE FOR CLINICAL TRIALS, TO HELP PATIENTS TO ENROLL IN CLINICAL
   11  TRIALS  AND TO ASSIST PATIENTS IN DEALING WITH INSURANCE OR OTHER ISSUES
   12  WHICH SERVE AS BARRIERS TO PATIENT ENROLLMENT IN CLINICAL TRIALS.
   13    3. APPLICATIONS. THE COMMISSIONER SHALL ESTABLISH AN APPLICATION PROC-
   14  ESS BY WHICH ELIGIBLE APPLICANTS  MAY  APPLY  FOR  A  GRANT  UNDER  THIS
   15  SECTION.  THE APPLICATION SHALL INCLUDE:
   16    A. THE GEOGRAPHIC AREA IN WHICH THE SERVICES SHALL BE PROVIDED;
   17    B. A DETAILED DESCRIPTION OF THE SERVICES TO BE PROVIDED;
   18    C.  APPLICANT'S EXPERIENCE WORKING WITH PATIENTS WITH LIFE-THREATENING
   19  OR DISABLING CONDITIONS OR DISEASES;
   20    D. APPLICANT'S ABILITY TO PROVIDE PATIENT OUTREACH OR  CLINICAL  TRIAL
   21  EDUCATION  AND NAVIGATION SERVICES, OR COORDINATE OR PROVIDE TRANSPORTA-
   22  TION AND LODGING FOR PATIENTS; AND
   23    E. ANY OTHER INFORMATION THAT  THE  COMMISSIONER  DEEMS  RELEVANT  AND
   24  APPROPRIATE.
   25    THE COMMISSIONER SHALL GIVE PREFERENCE TO ELIGIBLE APPLICANTS WHO HAVE
   26  EXPERIENCE  AND EXPERTISE WORKING WITH PATIENTS WITH LIFE-THREATENING OR
   27  DISABLING CONDITIONS OR DISEASES AND PROVIDING PATIENT OUTREACH,  EDUCA-
   28  TION AND HEALTH CARE NAVIGATION SERVICES.
   29    4.  REPORTS. GRANTEES SHALL FILE AN ANNUAL REPORT WITH THE COMMISSION-
   30  ER, IN SUCH FORM AND WITH SUCH INFORMATION AND DATA AS THE  COMMISSIONER
   31  PRESCRIBES  DETAILING THE EXPENDITURE OF GRANT FUNDS AND SUMMARIZING THE
   32  EFFORTS UNDERTAKEN TO INCREASE PATIENT ACCESS TO CLINICAL TRIALS.
   33    5. THE COMMISSIONER SHALL MAKE  REGULATIONS  REASONABLY  NECESSARY  TO
   34  IMPLEMENT THE PROVISIONS OF THIS SECTION.
   35    S 2. This act shall take effect immediately.
Go to top
Page display time = 0.1363 sec